EMERALD MUTUAL FUND ADVISERS TRUST - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2024$29,998,731
+0.1%
278,333
-11.9%
1.57%
+0.8%
Q1 2024$29,958,590
-14.6%
315,819
-16.9%
1.56%
-16.0%
Q4 2023$35,075,182
+50.4%
380,260
-18.1%
1.86%
+32.0%
Q3 2023$23,318,201
-10.7%
464,321
+12.3%
1.41%
-0.7%
Q2 2023$26,122,266
+61.8%
413,327
+15.2%
1.42%
+48.5%
Q1 2023$16,143,312
+20.5%
358,820
+17.4%
0.95%
+15.1%
Q4 2022$13,393,111
-19.9%
305,709
+20.5%
0.83%
-21.5%
Q3 2022$16,713,000
-29.8%
253,645
+14.1%
1.06%
+25.9%
Q4 2021$23,802,000
-5.7%
222,217
-9.5%
0.84%
-4.0%
Q3 2021$25,246,000
+16.9%
245,5570.0%0.87%
+23.6%
Q2 2021$21,599,000
-20.4%
245,557
-12.0%
0.71%
-21.4%
Q1 2021$27,126,000
-14.2%
278,986
-1.0%
0.90%
-18.1%
Q4 2020$31,597,000
-6.5%
281,739
-22.7%
1.10%
-26.6%
Q3 2020$33,777,000
+21.2%
364,373
+2.0%
1.50%
+13.8%
Q2 2020$27,870,000
+31.0%
357,302
-1.8%
1.32%
-1.3%
Q1 2020$21,273,000363,7721.33%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders